MedPath

Efficacy of propranolol in wound healing for hospitalized burn patients

Not Applicable
Conditions
Burn wound treatment.
Burns and corrosions
T20,T21,T2
Registration Number
IRCT138712041605N2
Lead Sponsor
Vice-chancellorship for Research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
79
Inclusion Criteria

Burn size 20% to 50% of the total body surface area (TBSA)
Exclusion criteria: Presence of cardiac or endocrine diseases, peripheral vascular disease, history of asthma, systolic blood pressure<90 and heart rate<60 after primary resuscitation, and inhalation injury.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Wound healing time. Timepoint: daily. Method of measurement: time between admission and epithelialization or preparation for skin graft.;Surface area of wounds needed to be grafted. Timepoint: daily. Method of measurement: by specific ruller.;Level of hemoglobin. Timepoint: twice a week. Method of measurement: cell counter (sysmeex).;Serum albumin level. Timepoint: twice a week. Method of measurement: check serum albumin level by BCG method (Bromocresol green).
Secondary Outcome Measures
NameTimeMethod
Hospital stay period. Timepoint: daily. Method of measurement: time of admission in the hospitals in days.
© Copyright 2025. All Rights Reserved by MedPath